Suppr超能文献

重复关节腔内注射富血小板血浆对早期膝关节骨关节炎临床疗效的影响。

The effects of repeated intra-articular PRP injections on clinical outcomes of early osteoarthritis of the knee.

作者信息

Gobbi Alberto, Lad Dnyanesh, Karnatzikos Georgios

机构信息

O.A.S.I. Bioresearch Foundation, Via Amadeo 24, 20133, Milan, Italy.

出版信息

Knee Surg Sports Traumatol Arthrosc. 2015 Aug;23(8):2170-2177. doi: 10.1007/s00167-014-2987-4. Epub 2014 Apr 20.

Abstract

PURPOSE

To assess the outcome of intra-articular platelet-rich plasma (PRP) injections into the knee in patients with early stages of osteoarthritis (OA) and to determine whether cyclical dosing would affect the end result.

METHODS

This is a prospective, randomized study in which 93 patients (119 knees) were followed up for a minimum of 2 years. Fifty knees were randomly selected prior to the first injection, to receive a second cycle at the completion of 1 year. A cycle consisted of three injections, each given at a monthly interval. The outcome was assessed using Knee Injury and Osteoarthritis Outcome Score (KOOS), Visual Analogue Scale (VAS), Tegner and Marx scoring systems, recorded prior to the first injection and then at 12, 18 and 24 months.

RESULTS

There was a significant improvement in all scores over time compared to the pre-treatment value (p < 0.001). At 12 months, both groups showed similar and significant improvement. At 18 months, except for KOOS (Symptoms) and Tegner score, all other parameters showed a significant difference between the two groups in favour of the patients who had received the second cycle (p < 0.001). At 2 years, the scores declined in both groups but remained above the pre-treatment value with no significant difference between the groups despite the patients with two cycles showing higher mean values for all the scores.

CONCLUSION

Intra-articular PRP injections into the knee for symptomatic early stages of OA are a valid treatment option. There is a significant reduction in pain and improvement in function after 12 months, which can be further improved at 18 months by annual repetition of the treatment. Although the beneficial effects are ill sustained at 2 years, the results are encouraging when compared to the pre-treatment function.

LEVEL OF EVIDENCE

II.

摘要

目的

评估向早期骨关节炎(OA)患者膝关节内注射富血小板血浆(PRP)的效果,并确定周期性给药是否会影响最终结果。

方法

这是一项前瞻性随机研究,对93例患者(119个膝关节)进行了至少2年的随访。在首次注射前随机选择50个膝关节,在1年结束时接受第二个疗程。一个疗程包括三次注射,每次间隔一个月。在首次注射前以及之后的12、18和24个月,使用膝关节损伤和骨关节炎疗效评分(KOOS)、视觉模拟量表(VAS)、特格纳和马克思评分系统评估结果。

结果

与治疗前值相比,所有评分随时间均有显著改善(p < 0.001)。在12个月时,两组均显示出相似且显著的改善。在18个月时,除了KOOS(症状)和特格纳评分外,所有其他参数在两组之间均显示出显著差异,有利于接受第二个疗程的患者(p < 0.001)。在2年时,两组评分均下降,但仍高于治疗前值,尽管接受两个疗程的患者所有评分的平均值较高,但两组之间无显著差异。

结论

对于有症状的早期OA患者,向膝关节内注射PRP是一种有效的治疗选择。12个月后疼痛显著减轻,功能改善,每年重复治疗可在18个月时进一步改善。虽然2年时有益效果维持不佳,但与治疗前功能相比,结果令人鼓舞。

证据水平

II级。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验